Just found this also.
http://sg.finance.yahoo.com/news/vincen ... 05129.html

Vincent Tan continues adding TMC Life shares
By Lee Wen Ai of theedgemalaysia.com | The Edge Malaysia – Fri, Dec 28, 2012 9:15 AM SGT
Email
RecommendTweet
Print
KUALA LUMPUR: Tan Sri Vincent Tan Chee Yioun has continued to accumulate shares this month in TMC Life Sciences Bhd, in which he is a substantial shareholder, via Berjaya Corp Bhd (BCorp), raising his indirect interest in the medical group to 31.83% as at Dec 24.
Tan added some 6.6 million shares via purchases on the open market in December, increasing his stake to 255.4 million shares or 31.83% from 31.01% as at end-November. As at end-October, Tan had an indirect 30.9% interest in TMC Life.
The current single largest shareholder in the company is Hong Kong-based Gilberta Investments Ltd, controlled by Singapore billionaire Peter Lim Eng Hock, with a 32.59% stake. This is followed by a 31.83% stake held by BCorp which is controlled by Tan.
In 2010, Lim snapped up a 29.6% stake in the medical group specialising in fertility treatment when Tan had a 31.7% indirect stake.
TMC Life announced recently its improved financials with its revenue rising 31% to RM16.4 million in the first quarter ended Aug 31 from RM12.4 million in the previous corresponding quarter. The jump in revenue was driven mainly by high patient load, both local and foreign, with increased bed capacity and more disciplines offered.
It posted a net profit of RM2.78 million for the quarter compared with a net loss of RM2.33 million a year ago. Earnings per share stood at 0.38 sen compared to a loss per share of 0.39 sen a year ago.
The improvement was mainly attributed to higher revenue coupled with a reduction in interest expenses from its repayment of RM39 million in bank borrowings at end-December 2011.
The company has been loss-making in the last three financial years.
TMC’s share price has been on a uptrend since mid-September, rising 29.3% from 29 sen to 37.5 sen yesterday.
In August, the company divested its entire investment in Tropicana Medical Centre in Penang for RM2.6 million, the properties it occupied to run the hospital operations for RM11 million and its entire investment in Stemtech International Sdn Bhd for RM800,000.
Chairman Datuk Dr Khalid Abdul Kadir had earlier said the company is expected to see improved earnings as its strategy to halve its non-performing assets to pare down debt is paying off.
This article first appeared in The Edge Financial Daily, on Dec 28, 2012.